Showing results (31-40 of 86) with videos related to
Sort By:
Pageof 9
International Journal of Hepatology|April 15, 2025
Hepatocellular Carcinoma and Health-Related Quality of Life: A Systematic Review of Outcomes From Systemic TherapiesDujinthan Jayabalan, Sugam Dhakal, Aarohanan Raguragavan, et al.Liver International : Official Journal of the International Association for the Study of the Liver|September 17, 2013
Prediction of morbidity and mortality in patients with chronic hepatitis C by non-invasive liver fibrosis modelsMohamed A Chinnaratha, Gary P Jeffrey, Gerry MacQuillan, et al.Journal of Molecular Histology|July 31, 2009
Ultra-structural localisation of hepatocellular PKR protein using immuno-gold labelling in chronic hepatitis C virus diseaseGerry C MacQuillan, Paul Caterina, Bastiaan de Boer, et al.Digestive Diseases and Sciences|May 30, 2018
The Prognostic Ability of Major Hepatocellular Carcinoma Staging Systems Is Improved by Including a Treatment VariableMichael C Wallace, Matthew Knuiman, Yi Huang, et al.Liver International : Official Journal of the International Association for the Study of the Liver|March 26, 2018
Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver diseaseLuis C Bertot, Gary P Jeffrey, Bastiaan de Boer, et al.Journal of Clinical Medicine|October 29, 2020
Changes in the Epidemiology of Hepatobiliary Disease Complicating Type 2 Diabetes over 25 Years: The Fremantle Diabetes StudyTimothy M E Davis, Kirsten E Peters, S A Paul Chubb, et al.Journal of Medical Imaging and Radiation Oncology|January 11, 2017
Transjugular intrahepatic portosystemic shunt: Indications, complications, survival and its use as a bridging therapy to liver transplant in Western AustraliaPuraskar Pateria, Gary P Jeffrey, George Garas, et al.Immunology and Cell Biology|July 18, 2002
Immunological markers predicting outcome in patients with hepatitis C treated with interferon-alpha and ribavirinSilvia Lee, Gerry C Macquillan, Niamh M Keane, et al.Gastroenterology|March 27, 2007
Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantationEdward J Gane, Peter W Angus, Simone Strasser, et al.Journal of Gastroenterology and Hepatology|April 23, 2002
Disease recurrence after liver transplantation in Western AustraliaIan F Yusoff, Anthony K House, W Bastiaan De Boer, et al.Pageof 9